Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
The Prevention and Treatment of SIRS in Patients With Cholestatic Jaundice After Operation.
Sponsor: Wanqing Gu
Listed as NCT02279147, this PHASE1/PHASE2 trial focuses on Jaundice, Obstructive and Systemic Inflammatory Response Syndrome and remains ongoing. Sponsored by Wanqing Gu, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wanqing Gu
For direct contact, visit the study record on ClinicalTrials.gov .